BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 7
• 8
• 9
• 10
• 11
• 14
• 15
• 16
• 17
• 18
• 21
• 22
• 23
• 24
• 25
• 29
• 30
• 31

• Business

  Symmetry Medical Inc. Reports First Quarter 2012 Financial Results

  May 3, 2012

   · 

  1 min read
• Business

  Charles River Laboratories (Massachusetts) Announces First-Quarter 2012 Results from Continuing Operations

  May 3, 2012

   · 

  1 min read
• Business

  Aerocrine: Interim report January – March 2012

  May 3, 2012

   · 

  1 min read
• Drug Development

  Sunesis Pharmaceuticals, Inc. Receives European Orphan Drug Designation for Vosaroxin to Treat Acute Myeloid Leukemia

  May 3, 2012

   · 

  1 min read
• Drug Development

  Exelixis, Inc. Expands the Cabozantinib Development Program Through NCI-CTEP Collaboration

  May 3, 2012

   · 

  1 min read
• Business

  Synta Pharmaceuticals Provides Clinical Update and Reports First Quarter 2012 Financial Results

  May 3, 2012

   · 

  1 min read
• Business

  ArQule, Inc. Reports First Quarter 2012 Financial Results

  May 3, 2012

   · 

  1 min read
• Biotech Beach

  Synteract, Inc. (San Diego) and Rempex Pharmaceuticals Partner in “Great Strides” Walk to Support Cystic Fibrosis Cure

  May 3, 2012

   · 

  2 min read
• Deals

  Kensey Nash Corporation Agrees to Be Acquired by Royal DSM for $38.50 per Share in Cash

  May 3, 2012

   · 

  7 min read
• Lone Star Bio

  Lexicon Pharmaceuticals, Inc. Receives Funding for Phase 2 Clinical Trial of LX4211 in Type 1 Diabetes

  May 3, 2012

   · 

  5 min read